{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:13:49Z","timestamp":1761128029396},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.diagmicrobio.2003.11.001","type":"journal-article","created":{"date-parts":[[2004,1,22]],"date-time":"2004-01-22T10:19:43Z","timestamp":1074766783000},"page":"277-282","source":"Crossref","is-referenced-by-count":4,"title":["A pragmatic approach to identify extended-spectrum \u03b2-lactamase-producing klebsiella pneumoniae in taiwan: in vitro activity of newer and established antimicrobial agents"],"prefix":"10.1016","volume":"48","author":[{"given":"Wen-Liang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Ching","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0732-8893(99)00106-6","article-title":"In vitro evaluation of cefepime and other broad-spectrum \u03b2-lactams in Taiwan Medical Centers","volume":"35","author":"Biedenbach","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jac\/46.2.327","article-title":"Detection of extended-spectrum \u03b2-lactamases with Etest and double-disc potentiation methods","volume":"46","author":"Brown","year":"2000","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0732-8893(99)00109-1","article-title":"High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan","volume":"36","author":"Chang","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/JCM.34.8.1880-1884.1996","article-title":"Detection of extended-spectrum \u03b2-lactamases (ESBL)-producing strain by the Etest ESBL screen","volume":"34","author":"Cormican","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/313710","article-title":"Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998","volume":"30","author":"Fluit","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB6","first-page":"239","article-title":"Surveillance of antibiotic resistance in Taiwan","volume":"32","author":"Ho","year":"1998","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0891-5520(05)70395-0","article-title":"Extended-spectrum \u03b2-lactamases and other enzymes providing resistance to oxyimino-\u03b2-lactams","volume":"11","author":"Jacoby","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB8","first-page":"661","article-title":"Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum \u03b2-lactam antibiotics","volume":"97","author":"Jan","year":"1998","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0732-8893(99)00110-8","article-title":"Summation","volume":"35","author":"Jones","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.diagmicrobio.2003.11.001_BIB10","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/314054","article-title":"In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance","volume":"31","author":"Jones","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0732-8893(00)00115-2","article-title":"Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia","volume":"37","author":"Jones","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.40.2.342","article-title":"In vitro selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins","volume":"40","author":"Martinez-Martinez","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"10.1016\/j.diagmicrobio.2003.11.001_BIB13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/jac\/45.suppl_3.13","article-title":"In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA","volume":"45","author":"McCloskey","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB14","unstructured":"National Committee for Clinical Laboratory Standards. (2003a). Performance standards for antimicrobial disk susceptibility tests, Eighth Edition: Approved Standard M2-A8. NCCLS, Wayne, PA"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB15","unstructured":"National Committee for Clinical Laboratory Standards. (2003b). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, sixth edition: approved standard M7-A6. NCCLS, Wayne, PA"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB16","unstructured":"National Committee for Clinical Laboratory Standards. (2003c). Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S13. NCCLS, Wayne, PA"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1469-0691.2000.00107.x","article-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)","volume":"6","author":"Paterson","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB19","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.42.7.1762","article-title":"Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)","volume":"42","author":"Pfaller","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB20","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/JCM.37.12.4020-4027.1999","article-title":"Bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward","volume":"37","author":"Siu","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/45.5.685","article-title":"In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respiratory tract, urinary tract and surgical infectious during 1997-1998 in Japan","volume":"45","author":"Tsurumaki","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB22","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/JCM.40.9.3121-3126.2002","article-title":"Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 \u03b2-lactamase in a university hospital in Taiwan","volume":"40","author":"Yan","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3201\/eid0805.010346","article-title":"Cefepime MIC as a predictor of extended-spectrum \u03b2-lactamase type in Klebsiella pneumoniae","volume":"8","author":"Yu","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1128\/AAC.46.4.1098-1100.2002","article-title":"First description of Klebsiella pneumoniae harboring CTX-M \u03b2-lactamases (CTX-M-14 and CTX-M-3) in Taiwan","volume":"46","author":"Yu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB25","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1128\/JCM.40.12.4666-4669.2002","article-title":"Molecular epidemiology of extended-spectrum \u03b2-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan","volume":"40","author":"Yu","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.11.001_BIB26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jac\/41.5.527","article-title":"Epidemiologic typing of Klebsiellae with extended-spectrum \u03b2-lactamases from European intensive care units","volume":"41","author":"Yuan","year":"1998","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T06:17:21Z","timestamp":1585462641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889303002414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0732889303002414"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2003.11.001","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}